Shares of Indoco Remedies Ltd surged 3% on 4 October after the company announced receiving final approval from the US Food and Drug Administration (USFDA)...
Shares of Indoco Remedies were trading 4% below on 20 October after the USFDA (the United States Food and Drug Administration) issued four observations for...
The USFDA has completed the inspection of Indoco Remedies, API manufacturing facilities at Patalganga and Rabale, Navi Mumbai. In a release the company stated that, the inspection...
Indoco Remedies has received statement for non compliance and restricted GMP certificate, to allow continued manufacture and testing of products considered to be medically critical or...
Indoco Remedies has received accreditation renewal, from Japanese regulatory authorities. The company is a fully integrated, research oriented pharma company engaged in the manufacturing and marketing...
Indoco Remedies has received certification for its Goa plant. It has received European GMP certification from Regulatory Authority of Hungary for its manufacturing facility, for non-sterile...